Company intelligence / Profile preview
Kexing Biopharm
Jinan, Shandong Province, Chinakexing.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Phase 3
01
Overview
Kexing Biopharm has a robust commercial portfolio of recombinant biologics and microecological agents with leading positions in China’s market. Its pipeline includes innovative antivirals such as GB05 for pediatric RSV infection now in Phase III trials in China and IND-approved for US trials. Other advanced candidates include long-acting growth hormone Fc-fusion proteins and nanobody-based therapies targeting cancer cachexia. The company invests heavily in R&D with a focus on innovation-driven international expansion
- Therapeutic areas
- GastroenterologyNephrologyEndocrinologyOncologyInfectious Diseases
- Modalities
- Recombinant proteinsmonoclonal antibodies (mAbs)microecological agents (probiotics)nucleic acid drugssmall molecules
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Kexing Biopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kexing Biopharm.